To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Business

Boston.com

Genzyme: New Framingham plant begins shipping Fabrazyme drug

By Chris Reidy

 |  Globe Staff  

  March 01, 2012

Genzyme Corp. said today that it has begun shipping doses of its Fabrazyme drug from its new plant in Framingham. The move follows an announcement in January that federal regulators had given Cambridge-based Genzyme the approval to begin producing Fabrazyme at the company’s new Framingham plant. With the Framingham plan coming on line, patients in the United States are now able to return to full dosing following a shortage. Fabrazyme treats Fabry’s disease, a rare enzyme deficiency.

Stay with the story. Get full access to BostonGlobe.com for just 99¢

Unlimited access to BostonGlobe.com for only 99¢ for the first 4 weeks. You can cancel at any time.

  • The FULL story all day: Enjoy all of the high-quality, in-depth journalism in the print edition of the Boston Globe — plus breaking news that's updated 24/7.
  • A truly reader-friendly format: It's online news that looks and reads just like the newspaper — uncluttered, uninterrupted.
  • Breakthrough technology: The responsive design automatically adapts content so it always reads perfectly on the digital device of your choice.
Get started today

Free access for home delivery subscribers.

Just need to link your home delivery account; one easy step.

Link my home delivery account

BostonGlobe.comSubscriber Log In

Contact us for help